Cargando…

Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma

SIMPLE SUMMARY: This review explores the current trials using cellular immunotherapies in pediatric sarcoma and describes examples of promising new CAR T targets in sarcoma that are in preclinical development. We provide insights into the ways in which the immunosuppressive tumor immune microenviron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terry, Rachael L., Meyran, Deborah, Fleuren, Emmy D. G., Mayoh, Chelsea, Zhu, Joe, Omer, Natacha, Ziegler, David S., Haber, Michelle, Darcy, Phillip K., Trapani, Joseph A., Neeson, Paul J., Ekert, Paul G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465026/ https://www.ncbi.nlm.nih.gov/pubmed/34572932 http://dx.doi.org/10.3390/cancers13184704

Ejemplares similares

Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors
por: Fleuren, Emmy D. G., et al.
Publicado: (2021)

Advances in CAR T cell immunotherapy for paediatric brain tumours
por: Rao, Padmashree, et al.
Publicado: (2022)

Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers
por: Brown, Lauren M., et al.
Publicado: (2023)

Chimeric Antigen Receptor beyond CAR-T Cells
por: Qin, Vicky Mengfei, et al.
Publicado: (2021)

Recurrent SPECC1L–NTRK fusions in pediatric sarcoma and brain tumors
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2020)

Systemic Treatment for Adults with Synovial Sarcoma
por: Desar, Ingrid M. E., et al.
Publicado: (2018)

A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
por: Mayoh, Chelsea, et al.
Publicado: (2023)

CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors
por: Qin, Vicky Mengfei, et al.
Publicado: (2022)

Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma
por: Fleuren, Emmy D. G., et al.
Publicado: (2023)

PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia
por: Li, Jessica, et al.
Publicado: (2020)

Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma
por: Subhash, Vinod Vijay, et al.
Publicado: (2021)

Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity
por: Davenport, A. J., et al.
Publicado: (2018)

The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells
por: Richardson, Kelden, et al.
Publicado: (2022)

Switching on the green light for chimeric antigen receptor T‐cell therapy
por: Mardiana, Sherly, et al.
Publicado: (2019)

Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes
por: Ajuyah, Pamela, et al.
Publicado: (2023)

Myeloma natural killer cells are exhausted and have impaired regulation of activation
por: D’Souza, Criselle, et al.
Publicado: (2021)

A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer
por: Yong, Carmen S.M., et al.
Publicado: (2016)

Challenges of PD-L1 testing in non-small cell lung cancer and beyond
por: Wang, Minyu, et al.
Publicado: (2020)

Preclinical Evidence of the Efficacy of Lewis Y Car T Cells in Patient-Derived Models of Prostate Cancer
por: Risbridger, Gail Petuna, et al.
Publicado: (2021)

Lethal Dermal Sarcoma in Immunosuppressed Patients
por: Azin, Marjan, et al.
Publicado: (2022)

Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
por: Nagabushan, Sumanth, et al.
Publicado: (2021)

Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients
por: Vlenterie, Myrella, et al.
Publicado: (2016)

DIPG-75. PRECISION MEDICINE FOR PAEDIATRIC HIGH-GRADE DIFFUSE MIDLINE GLIOMAS - RESULTS FROM THE ZERO CHILDHOOD CANCER COMPREHENSIVE PRECISION MEDICINE PROGRAM
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2020)

Therapeutic strategies to remodel immunologically cold tumors
por: Wang, Minyu, et al.
Publicado: (2020)

Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma
por: Ziegler, David S., et al.
Publicado: (2018)

Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
por: John, Liza B, et al.
Publicado: (2013)

Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities
por: Chan, Jack D., et al.
Publicado: (2020)

DIPG-15. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
por: Khan, Aaminah, et al.
Publicado: (2020)

RARE-02. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
por: Khan, Aaminah, et al.
Publicado: (2021)

Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma.
por: Luiten, R. M., et al.
Publicado: (1996)

The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma
por: Fleuren, Emmy D.G., et al.
Publicado: (2014)

Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment
por: Hsu, Brend Ray-Sea, et al.
Publicado: (2017)

Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells
por: Chan, Jack D, et al.
Publicado: (2020)

Enhancing Natural Killer Cell Targeting of Pediatric Sarcoma
por: Omer, Natacha, et al.
Publicado: (2021)

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
por: Giuffrida, Lauren, et al.
Publicado: (2021)

A Novel Treatment for Ewing’s Sarcoma: Chimeric Antigen Receptor-T Cell Therapy
por: Lin, Zili, et al.
Publicado: (2021)

Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcoma
por: Watters, Chelsae R., et al.
Publicado: (2023)

Iatrogenic Kaposi's sarcoma after immunosuppressive treatment for granulomatosis with polyangiitis (Wegener's)
por: Saxena, Anjali, et al.
Publicado: (2015)

Novel Human Umbilical Di-Chimeric (HUDC) cell therapy for transplantation without life-long immunosuppression
por: Siemionow, Maria, et al.
Publicado: (2023)

Pinnacle Liquid edition 6 for Windows
por: Ekert, Paul
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_v1q2v9qpb08fuctt09binta3st